Biopsy Devices Market - Forecasts from 2018 to 2023
The Biopsy devices market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. Growing prevalence of cancer, increasing awareness for the diagnosis of chronic disease is considered as the key factors driving the growth of the market. Moreover increasing demand for minimally invasive surgeries and technological advancements in biopsy guiding systems also fuels up the growth of the market. According to World Health Organization Cancer is the second leading cause of death globally, and is responsible for nearly 9.6 million deaths in 2018. Moreover widening base of geriatric population and introduction of cost effective devices are further expected to further boost the growth of the market.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Biopsy devices value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the Biopsy devices market.
Major industry players profiled as part of the report are Becton, Dickinson and Company, Argon Medical Devices, Inc., C. R. Bard, Inc., Cardinal Health, Inc. and Devicor Medical Products, Inc. among others.
B. Braun Melsungen AG , Olympus Corporation, Fujifilm Holdings Corporation, Inrad, Inc., Cook Group Incorporated, Boston Scientific Corporation
The Biopsy devices market has been analyzed through following segments:
Bone marrow biopsy
Ambulatory Surgical Centers
Academic and research institute
By Guidance Technique
Computed tomography (CT)
Magnetic resonance imaging
Middle East and Africa
Key insights offered
What will be the Biopsy devices market size from 2017 to 2023?
How are the major drivers and restraints affecting the Biopsy devices market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.
Becton, Dickinson and Company
Argon Medical Devices, Inc.
C. R. Bard, Inc.
Cardinal Health, Inc.
Devicor Medical Products, Inc. (Mammotome)
B. Braun Melsungen AG
Fujifilm Holdings Corporation
Cook Group Incorporated
Boston Scientific Corporation